Skip to main content
. 2015 Jun 15;13:201. doi: 10.1186/s12957-015-0611-9

Table 5.

Adverse events in the study

No. of patients with CTCAE grade (%)
Adverse event 1 (%) 2 (%) 3 (%) 4 (%)
AST/ALT 21 (55.3) 6 (15.8) 4 (10.5) 1 (2.6)
Alkaline-phosphatase 3 (7.9)
Bilirubin 12 (31.6) 2 (5.3) 3 (7.9) 2 (5.3)
Gastroduodenitis 2 (5.3) 1 (2.6)
Gastric ulcer 2 (5.3) 1 (2.6)
Duodenal ulcer 1 (2.6) 1 (2.6)

CTCAE Common Terminology Criteria for Adverse Events, AST aspartate aminotransferase, ALT alanine aminotransferase